02242nas a2200289 4500000000100000008004100001260004400042653002400086653005700110653002800167100001200195700001400207700001400221700001300235700001700248700001600265700001500281700001300296700002000309700001300329700001400342245013700356856008500493490000700578520135300585022001401938 2022 d bSpringer Science and Business Media LLC10aInfectious Diseases10aPublic Health, Environmental and Occupational Health10aUrinary schistosomiasis1 aShams M1 aKhazaei S1 aGhasemi E1 aNazari N1 aJavanmardi E1 aMajidiani H1 aBahadory S1 aAnvari D1 aFatollahzadeh M1 aNemati T1 aAsghari A00aPrevalence of urinary schistosomiasis in women: a systematic review and meta-analysis of recently published literature (2016–2020) uhttps://tropmedhealth.biomedcentral.com/track/pdf/10.1186/s41182-022-00402-x.pdf0 v503 a

Abstract Background Urinary schistosomiasis is a serious threat in endemic territories of Africa and the Middle East. The status of female urinary schistosomiasis (FUS) in published literature between 2016 and 2020 was investigated. Methods A systematic search in PubMed, Scopus, Google Scholar, and Web of Science, based on the ‘Preferred Reporting Items for Systematic Reviews and Meta-analyses’ checklist, and a meta-analysis using random-effects model to calculate the weighted estimates and 95% confidence intervals (95% CIs) were done. Results Totally, 113 datasets reported data on 40,531 women from 21 African countries, showing a pooled prevalence of 17.5% (95% CI: 14.8–20.5%). Most studies (73) were performed in Nigeria, while highest prevalence was detected in Mozambique 58% (95% CI: 56.9–59.1%) (one study). By sample type and symptoms, vaginal lavage [25.0% (95% CI: 11.4–46.1%)] and hematuria 19.4% (95% CI: 12.2–29.4%) showed higher FUS frequency. Studies using direct microscopy diagnosed a 17.1% (95% CI: 14.5–20.1%) prevalence rate, higher than PCR-based studies 15.3% (95% CI: 6.1–33.2%). Except for sample type, all other variables had significant association with the overall prevalence of FUS. Conclusions More studies are needed to evaluate the true epidemiology of FUS throughout endemic regions.

 a1349-4147